MTD vs. A, WAT, ILMN, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMO
Should you be buying Mettler-Toledo International stock or one of its competitors? The main competitors of Mettler-Toledo International include Agilent Technologies (A), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.
Mettler-Toledo International vs.
Mettler-Toledo International (NYSE:MTD) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, community ranking, institutional ownership and earnings.
Mettler-Toledo International has a net margin of 22.29% compared to Agilent Technologies' net margin of 19.27%. Agilent Technologies' return on equity of 25.56% beat Mettler-Toledo International's return on equity.
Mettler-Toledo International has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.
Agilent Technologies has higher revenue and earnings than Mettler-Toledo International. Agilent Technologies is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
Agilent Technologies received 494 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 71.08% of users gave Agilent Technologies an outperform vote while only 56.55% of users gave Mettler-Toledo International an outperform vote.
Mettler-Toledo International presently has a consensus price target of $1,380.50, indicating a potential upside of 15.42%. Agilent Technologies has a consensus price target of $150.83, indicating a potential upside of 26.71%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Agilent Technologies is more favorable than Mettler-Toledo International.
95.1% of Mettler-Toledo International shares are owned by institutional investors. 1.9% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Agilent Technologies had 15 more articles in the media than Mettler-Toledo International. MarketBeat recorded 39 mentions for Agilent Technologies and 24 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.49 beat Agilent Technologies' score of 1.13 indicating that Mettler-Toledo International is being referred to more favorably in the media.
Summary
Mettler-Toledo International and Agilent Technologies tied by winning 9 of the 18 factors compared between the two stocks.
Get Mettler-Toledo International News Delivered to You Automatically
Sign up to receive the latest news and ratings for MTD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Mettler-Toledo International Competitors List
Related Companies and Tools
This page (NYSE:MTD) was last updated on 3/28/2025 by MarketBeat.com Staff